INHIBITION, BY VINCA ALKALOIDS AND COLCHICINE, OF ANTIGENIC MODULATION INDUCED BY ANTI-CD19 MONOCLONAL-ANTIBODIES

被引：17
|
作者：
DERIE, MA [1 ]
ZEIJLEMAKER, WP [1 ]
VONDEMBORNE, AEGK [1 ]
机构：
[1] UNIV AMSTERDAM,DEPT HAEMATOL,ACAD MED CTR,AMSTERDAM,NETHERLANDS
来源：
LEUKEMIA RESEARCH | 1988年 / 12卷 / 02期
关键词：
D O I：
10.1016/0145-2126(88)90073-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 141
页数：7
相关论文
共 50 条
  • [21] Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies
    D Ma
    MR McDevitt
    E Barendswaard
    L Lai
    MJ Curcio
    V Pellegrini
    MW Brechbiel
    DA Scheinberg
    Leukemia, 2002, 16 : 60 - 66
  • [22] Non-depleting anti-CD19 B cell inhibition
    Robert Phillips
    Nature Reviews Rheumatology, 2023, 19 : 539 - 539
  • [23] Non-depleting anti-CD19 B cell inhibition
    Phillips, Robert
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (09) : 539 - 539
  • [24] Xmab™ Fc-engineered anti-cd19 monoclonal antibodies with in vitro and in vivo efficacy against lymphoma and leukemia
    Zhukovsky, Eugene
    Bernett, Matthew
    Chu, Seung
    Karki, Sher
    Horton, Holly
    Richards, John
    Pong, Erik
    Joyce, Patrick
    Peipp, Matthias
    Repp, Roland
    Desjarlais, John
    CANCER RESEARCH, 2008, 68 (09)
  • [25] ANTIGENIC NEURO-ECTODERMAL COMMUNITY DETECTED BY ANTI-NEUROBLASTOMA MONOCLONAL-ANTIBODIES
    BECK, D
    GROSS, N
    CARREL, S
    MUNOZ, M
    ARCHIVES FRANCAISES DE PEDIATRIE, 1985, 42 : 654 - 654
  • [26] SUPPRESSION OF THE TOXICITY AND IMMUNOGENICITY OF ANTI-CD3 MONOCLONAL-ANTIBODIES
    FINCK, BK
    WOFSY, D
    CLINICAL RESEARCH, 1991, 39 (02): : A435 - A435
  • [27] SELECTIVE RECOGNITION OF DNA ANTIGENIC DETERMINANTS BY MURINE ANTI-DNA MONOCLONAL-ANTIBODIES
    ARMITAGE, J
    WU, DP
    GILKESON, GS
    REICH, CF
    PISETSKY, DS
    CLINICAL RESEARCH, 1990, 38 (02): : A276 - A276
  • [28] MURINE ANTI-CD3 MONOCLONAL-ANTIBODIES - CHARACTERIZATION AND FUNCTIONS
    BOUREL, D
    GENETET, N
    CAROSELLA, E
    MERDRIGNAC, G
    GENETET, B
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 355 - 355
  • [29] INHIBITION OF LIPOPOLYSACCHARIDE MITOGENICITY WITH CHARACTERIZED ANTI-LIPID-A MONOCLONAL-ANTIBODIES
    GIRARD, R
    CHABY, R
    IMMUNOLOGY, 1985, 56 (03) : 481 - 487
  • [30] Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
    Tipton, Thomas R. W.
    Roghanian, Ali
    Oldham, Robert J.
    Carter, Matthew J.
    Cox, Kerry L.
    Mockridge, C. Ian
    French, Ruth R.
    Dahal, Lekh N.
    Duriez, Patrick J.
    Hargreaves, Philip G.
    Cragg, Mark S.
    Beers, Stephen A.
    BLOOD, 2015, 125 (12) : 1901 - 1909
12345